Haber M - Search Results

1

Isolated testicular relapse after allo-SCT in boys with ALL: outcome without second transplant.

Bhadri VA, McGregor MR, Venn NC, Hackenberg N, Russell SJ, Norris MD, Haber M, Sutton R, Marshall GM. Bhadri VA, et al. Among authors: haber m. Bone Marrow Transplant. 2010 Feb;45(2):397-9. doi: 10.1038/bmt.2009.138. Epub 2009 Jun 22. Bone Marrow Transplant. 2010. PMID: 19543328 No abstract available.

2

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW. Haber M, et al. Cancer Res. 1989 Oct 1;49(19):5281-7. Cancer Res. 1989. PMID: 2569932

3

Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.

Norris MD, Haber M, King M, Davey RA. Norris MD, et al. Among authors: haber m. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1435-41. doi: 10.1016/0006-291x(89)92764-2. Biochem Biophys Res Commun. 1989. PMID: 2575383

4

Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model.

White L, Haber M, Brian MJ, Norris MD, Trickett A, Sosula L, Tiley C, Stewart BW. White L, et al. Among authors: haber m. Cancer. 1989 Jun 1;63(11):2103-10. doi: 10.1002/1097-0142(19890601)63:11<2103::aid-cncr2820631106>3.0.co;2-n. Cancer. 1989. PMID: 2720561

5

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

6

Single-strand-specific degradation of DNA during isolation of rat liver nuclei.

Ward EJ, Haber M, Norris MD, Stewart BW. Ward EJ, et al. Among authors: haber m. Biochemistry. 1985 Oct 8;24(21):5803-9. doi: 10.1021/bi00342a018. Biochemistry. 1985. PMID: 3002423

7

Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.

Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H, et al. Marshall GM, et al. Among authors: haber m. Leukemia. 1995 Nov;9(11):1847-50. Leukemia. 1995. PMID: 7475273

8

Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers.

Norris MD, Kwan E, Haber M, Marshall GM. Norris MD, et al. Among authors: haber m. Leukemia. 1995 Oct;9(10):1779-82. Leukemia. 1995. PMID: 7564525

9

An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.

Haber M, Norris MD, Kavallaris M, Camacho M, Madafiglio J, Baker CJ, White L, Stewart BW. Haber M, et al. Cancer Lett. 1995 Oct 20;97(1):49-55. doi: 10.1016/0304-3835(95)03950-2. Cancer Lett. 1995. PMID: 7585477

10

Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.

Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M, Norris MD. Marshall GM, et al. Among authors: haber m. Oncogene. 1995 Aug 3;11(3):485-91. Oncogene. 1995. PMID: 7630632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters